\
&
Contact us
\
&
Contact us
Published on | 1 day ago
Programmes Climate, Energy, MobilityIn June 2024, the seventh EU-US Transportation Research Symposium was held in Washington. The theme of the event was "Behavioural, Social and Technological Research and Innovation (R&I), Strategies for Transportation Decarbonisation".
It is the perfect reading for those who are interested in mobility R&I on the international stage. Recently they have published the report of this symposium, which is a joint effort between the European Commission and the United States Department of Transportation, with valuable support from the Transportation Research Board and the EU-funded Sympeus project. You can find the full report here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital Europe AI, data & cloud Advanced Digital Skills Deployment: Best use of technologies
The upcoming calls from the Digital Europe Main Work Programme have been published on the Funding & Tenders Portal of the European Commission. The following 10 call topics are expected to open for submission on 15 April 2025, deadline to submit proposals will be 2 September 2025: AI, data & cloud Apply AI: GenAI for the public ad... read more
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
